On June 3, As part of the Oragenics Inc (NYSEMKT:OGEN)’s non-employee Director compensation program and in connection with the Company’s annual meeting, on May 30, 2014 each continuing non-employee Director Frederick Telling, Charles Pope, Alan Dunton, Christine Koski and Robert Koski was granted an award of 10,000 fully vested shares of the Company’s common stock under the Company’s 2012 Equity Incentive Plan. Oragenics Inc (NYSEMKT:OGEN) weekly performance is 27.04%. On last trading day company shares ended up $2.49. Analysts mean target price for the company is $7.00. Oragenics Inc (NYSEMKT:OGEN) distance from 50-day simple moving average (SMA50) is 13.77%.
On May 29, CAS Medical Systems, Inc. (NASDAQ:CASM) a leader in medical devices for non-invasive patient monitoring, announced that it has signed an agreement with Century Medical, Inc. to serve as the exclusive distributor of the Company’s FORE-SIGHT ELITE® Cerebral Oximeters in Japan. CAS Medical Systems Inc (NASDAQ:CASM) shares fell -3.59% in last trading session and ended the day on $1.88. Gross Margin is 34.20% and its return on assets is -73.10 %. CAS Medical Systems Inc (NASDAQ:CASM) quarterly performance is -10.05%.
On June 5, 2014, Lakeland Industries, Inc. (NASDAQ:LAKE) a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, will release its financial results for the fiscal 2015 first quarter ended April 30, 2014, on Thursday, June 12, 2014 at stock market close and will conduct a conference call on the same day at 4:30 p.m. eastern. Lakeland Industries, Inc. (NASDAQ:LAKE) shares moved up 0.48% in last trading session and was closed at $7.90, while trading in range of $7.63 – $7.96. Lakeland Industries, Inc. (NASDAQ:LAKE) year to date (YTD) performance is 50.19%.
On May 8, 2014, Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) received a letter from the Listing Qualifications department of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that its application to transfer the listing of its common stock to the Nasdaq Capital Market has been approved. Enzon Pharmaceuticals Inc (NASDAQ:ENZN) ended the last trading day at $1.18. Company weekly volatility is calculated as 10.14% and price to cash ratio as 3.50. Enzon Pharmaceuticals Inc (NASDAQ:ENZN) showed a positive weekly performance of 35.63%.
AdCare Health Systems, Inc. (NYSEMKT:ADK) a leading long-term care provider, announced that its Board of Directors has declared a quarterly cash dividend payment on the Company’s 10.875% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”), accruing from April 1, 2014 through June 30, 2014. AdCare Health Systems, Inc. (NYSEMKT:ADK) net profit margin is -7.70% and weekly performance is 7.50%. On last trading day company shares ended up $4.30. Analysts mean target price for the company is $7.50. AdCare Health Systems, Inc. (NYSEMKT:ADK) distance from 50-day simple moving average (SMA50) is 6.53%.